Clinical Trial Update: Effect of Lipid Lowering Agents on Diabetic Retinopathy and Cardiovascular Risk of Diabetic Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating lipid-lowering agents for diabetic retinopathy and cardiovascular risk in diabetic patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Snippet

Sponsor: Alaa Hassan ElBaz | Conditions: Diabetic Retinopathy | Phase 4 | Status: UNKNOWN